Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
์ข
๋ชฉ ์ฝ๋ ZLAB
ํ์ฌ ์ด๋ฆZai Lab Ltd
์์ฅ์ผSep 28, 2020
CEODu (Ying)
์ง์ ์1869
์ ํDepository Receipt
ํ๊ณ ์ฐ๋ ์ข
๋ฃSep 28
์ฃผ์Building B, 899 Halei Road, Pudong
๋์SHANGHAI
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐChina
์ฐํธ ๋ฒํธ201203
์ ํ862161632588
์น์ฌ์ดํธhttps://www.zailaboratory.com/
์ข
๋ชฉ ์ฝ๋ ZLAB
์์ฅ์ผSep 28, 2020
CEODu (Ying)
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์